International Journal of Antimicrobial Agents, published by Elsevier, stands as a premier platform in the fields of Infectious Diseases, Microbiology, and Medical Pharmacology. With an impressive impact factor and ranked in the Q1 category across multiple medical disciplines in 2023, this journal is recognized for its contribution to advancing knowledge and understanding in the efficacy and safety of antimicrobial treatments. Its comprehensive scope from 1991 to 2024 allows for the publishing of original research, reviews, and commentary on pressing issues related to antimicrobial resistance, treatment strategies, and pharmacological innovations. With a strong emphasis on high-quality research as reflected in its Scopus rankings, the journal is an essential resource for researchers, clinicians, and students dedicated to improving patient outcomes in the face of evolving microbiological challenges. Engage with the latest findings and methodologies through this vital academic resource, available in print and online, from the heart of the Netherlands.

Annals of Clinical Microbiology and Antimicrobials, published by BMC, is a leading open-access journal that has been fostering scientific discourse in the fields of microbiology and infectious diseases since its inception in 2002. With an established reputation for excellence, this journal is positioned in the prestigious Q1 category across multiple disciplines, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology as of 2023. This journal serves as a vital platform for researchers, healthcare professionals, and students, promoting the latest advancements in clinical microbiology and antimicrobial research. Access to its invaluable content is open to all, reflecting the commitment to disseminate knowledge universally. The Annals of Clinical Microbiology and Antimicrobials is based in the United Kingdom and continues to pave the way for innovation and discussions that shape the future of clinical practices in microbiology.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, published by Cambridge University Press, is a leading academic journal specializing in the critical fields of epidemiology, infectious diseases, and medical microbiology. With a history of publication dating back to 1988 and an expected continuation through 2024, the journal has established itself as a pivotal resource for researchers, healthcare professionals, and students alike. The journal's impact is reflected in its impressive rankings, positioning it in the second quartile for Epidemiology and the first quartile for both Infectious Diseases and Medical Microbiology as of 2023. This esteemed journal is dedicated to the dissemination of high-quality research that informs best practices in infection control and enhances patient safety across healthcare settings. Although access to its content is not open, the rigorous peer-review process ensures that all published articles contribute significantly to the body of knowledge in these vital areas. With a commitment to bridging the gap between research and practice, INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY remains an essential publication for those committed to the advancement of public health and the science of infection prevention.

Infection Prevention in Practice is a leading academic journal published by ELSEVIER that has established itself as a vital resource in the domains of Infectious Diseases and Public Health. With its Open Access policy implemented since 2019, the journal enhances global accessibility to cutting-edge research and practical insights aiming to reduce the risk of infections in various settings. It proudly holds a Q3 ranking in Infectious Diseases and a Q2 ranking in Public Health, Environmental and Occupational Health as of 2023, showcasing its impact and relevance within the scientific community—particularly with a Scopus rank placing it in the 71st percentile for public health research. Its scope includes the latest advancements, strategies, and practices in infection prevention, making it an indispensable read for researchers, healthcare professionals, and students dedicated to improving health outcomes and combating infectious diseases effectively. The journal operates from its base in the United Kingdom and reaches a global audience, fostering collaboration and innovation in infection control practices.

Revista de Epidemiologia e Controle de Infeccao, published by Universidade de Santa Cruz do Sul, stands as a vital resource for scholars and practitioners in the fields of epidemiology and infection control. This open-access journal, available since 2011, fosters the dissemination of high-quality research and practice-based knowledge aimed at enhancing public health and improving infection management strategies. With its commitment to sharing invaluable insights from Brazil and beyond, the journal encourages broader participation in critical discussions surrounding infectious diseases. Although specific metrics such as the HIndex and Scopus rankings are currently omitted, the journal's relevance is underscored by its open accessibility, allowing a global audience of researchers, healthcare professionals, and students to engage with innovative studies and findings in this essential area of public health.

Indian Journal of Medical Microbiology, published by Elsevier, is a pivotal peer-reviewed journal dedicated to the field of medical microbiology, providing a vital platform for research and scholarship since its inception in 1986. With an Open Access model established in 2001, it ensures the dissemination of scientific knowledge to a global audience, enhancing accessibility for researchers, professionals, and students alike. The journal's scope spans critical areas including immunology, infectious diseases, and microbiology, with an impressive trajectory marked by converged years of publication allowing for a comprehensive exploration of evolving scientific trends. As of 2023, the journal holds a Q3 ranking in Infectious Diseases and Microbiology (medical) and a Q4 ranking in Immunology and Microbiology categories, reflecting its significant yet growing impact in the field. Researchers seeking to contribute to or stay updated on the latest advancements in medical microbiology will find the Indian Journal of Medical Microbiology a valuable resource, as it consistently bridges the gap between emerging science and clinical application.

Journal of Infection and Public Health is a premier open-access journal published by ELSEVIER SCIENCE LONDON, dedicated to advancing knowledge in the fields of infectious diseases, public health, and environmental health. Since its inception in 2008, this esteemed journal has become a cornerstone of research dissemination, especially after transitioning to an open-access model in 2017, allowing wider accessibility to groundbreaking studies. With an impressive impact factor and ranking in the Q1 category for Infectious Diseases and Public Health as of 2023, the journal stands at the forefront of scientific inquiry, boasting a Scopus rank of #22 out of 665 in Public Health, underscoring its influence and reach in the academic community. Researchers, professionals, and students alike will find the journal's rich repository of peer-reviewed articles invaluable for ongoing education and practice in a rapidly evolving field. For contributing to the global understanding of health dynamics, Journal of Infection and Public Health is a vital resource, inviting scholars to explore, engage, and contribute to the crucial discussions shaping our world.

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, published by W B SAUNDERS CO-ELSEVIER INC, stands as a premier academic resource in the field of infectious diseases and microbiology. With its ISSN 0891-5520 and E-ISSN 1557-9824, this esteemed journal has been at the forefront of disseminating critical research findings and clinical advancements since its inception in 1987. Known for its high impact, the journal ranks in the Q1 category for both Infectious Diseases and Medical Microbiology as of 2023, which underscores its significant contribution to advancing knowledge and practice in these vital areas. Researchers, practitioners, and students alike rely on its comprehensive yet concise reviews and original articles, ensuring they stay abreast of emerging trends and therapeutics in infectious disease management. Although it does not offer open access, the journal remains pivotal in enriching scholarly dialogue and influencing clinical practices in the United States and beyond. Explore this vital publication and join a community dedicated to excellence in infectious disease research.

Infection and Chemotherapy, an esteemed journal published by the Korean Society of Antimicrobial Therapy, focuses on the dynamic fields of infectious diseases and pharmacology. With an ISSN of 2093-2340 and an E-ISSN of 2092-6448, this peer-reviewed, open-access journal has been providing a crucial platform for research dissemination since 2008. Based in South Korea, it boasts a significant impact in the academic community, as evidenced by its Q2 ranking in both Infectious Diseases and Pharmacology categories for 2023. It holds a Scopus rank of 64 out of 272 in Pharmacology and 98 out of 344 in Infectious Diseases, showcasing its prominence and the quality of research it publishes. With a focus on advancing scientific knowledge, Infection and Chemotherapy is committed to fostering essential dialogues among researchers, clinicians, and students, making it a vital resource for those engaged in the fight against infectious diseases and the development of effective therapeutic protocols.

The Brazilian Journal of Infectious Diseases, published by Elsevier Brazil, is a premier open-access journal dedicated to advancing research and clinical practice in the field of infectious diseases. Since its inception in 2001, this journal has been pivotal in disseminating innovative studies and reviews that inform healthcare professionals and researchers alike. With an impressive impact factor reflected by its ranking in the second quartile for Infectious Diseases and third quartile for Medical Microbiology in 2023, the journal ranks #127 out of 344 in medicine – infectious diseases and #61 out of 140 in medical microbiology, showcasing its reputable standing in the scientific community. The Brazilian Journal of Infectious Diseases invites contributions that highlight significant findings, novel methodologies, and critical reviews aimed at enhancing patient care and public health initiatives. With an international readership and a focus on pressing issues in infectious diseases, it serves as an essential platform for knowledge exchange and collaboration among scholars and practitioners across Brazil and beyond. By reinforcing the importance of open access to scientific literature, this journal not only promotes transparency but also enhances the global discourse surrounding infectious diseases.